Aldeyra Therapeutics
ALDX
#10254
Rank
A$74.87 M
Marketcap
A$1.24
Share price
14.37%
Change (1 day)
-83.43%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -A$32.05 Million

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$47.92 Million, an increase over its 2024 earnings that were of -A$80.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$32.05 Million-33.12%
2025 -A$47.92 Million-40.77%
2024 -A$80.9 Million52.03%
2023 -A$53.22 Million-41.21%
2022 -A$90.51 Million7.67%
2021 -A$84.06 Million55.1%
2020 -A$54.2 Million-41.29%
2019 -A$92.31 Million58.81%
2018 -A$58.13 Million74.32%
2017 -A$33.35 Million19.56%
2016 -A$27.89 Million55.21%
2015 -A$17.97 Million142.32%
2014 -A$7.42 Million-137.39%
2013 A$19.83 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$8.53 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA